Clinical Trial Update: Randomized, Double Blind, Placebo Control Trial to Evaluate the Efficacy of Astragalus Membranaceus in the Patients After Stroke With Fatigue [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind, placebo-controlled trial is evaluating the efficacy of Astragalus membranaceus for fatigue in patients after stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-stroke Fatigue
• Stroke

Drugs mentioned

• Astragalus membranaceus (Astragalus membranaceus)

Snippet

Sponsor: China Medical University Hospital | Conditions: Fatigue, Stroke | Phase 4 | Status: UNKNOWN